CMS spells out how states can join new cell and gene ther­a­py ac­cess pi­lot

The Cen­ters for Medicare and Med­ic­aid Ser­vices plans to be­gin test­ing whether out­comes-based agree­ments might im­prove ac­cess to two new gene ther­a­pies ap­proved for sick­le …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER